- NMTC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
NeuroOne Medical Technologies (NMTC) 10-K/A2019 FY Annual report (amended)
Filed: 28 Jan 20, 4:55pm
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a) OR 15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES OXLEY ACT OF 2002
I, David Rosa, certify that:
1 | I have reviewed Amendment No. 1 to the annual report on Form 10-K for the year ended September 30, 2019 (the “report”) of NeuroOne Medical Technologies Corporation; and |
2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: January 28, 2020 | ||
By: | /s/ David Rosa | |
Name: | David Rosa | |
Title: | Chief Executive Officer | |
(Principal Executive Officer and Principal Financial Officer) |